ArticleThe American journal of gastroenterology2001

Predictors of progression in Barrett's esophagus II: baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progression.

B J Reid et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.